GSK to buy US cancer drug firm IDRx for up to $1.15bnGSK is acquiring IDRx to strengthen its oncology business and address treatment gaps in gastrointestinal cancers.
UK firm GSK to pay $2.2bn over Zantac cancer claimsGSK is settling $2.2bn over Zantac cancer claims, resolving 93% of lawsuits without admitting wrongdoing.
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuitsGSK reported a £58 million loss due to Zantac settlement, contrasting with a £1.5 billion profit last year.
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuitsGSK has agreed to pay $2.3 billion to settle lawsuits over Zantac's alleged cancer risk, while denying any liability.
UK firm GSK to pay $2.2bn over Zantac cancer claimsGSK is settling $2.2bn over Zantac cancer claims, resolving 93% of lawsuits without admitting wrongdoing.
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuitsGSK reported a £58 million loss due to Zantac settlement, contrasting with a £1.5 billion profit last year.
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuitsGSK has agreed to pay $2.3 billion to settle lawsuits over Zantac's alleged cancer risk, while denying any liability.
FTSE 100 drifts lower ahead of latest Federal Reserve interest rate decisionThe FTSE 100 decreased due to oil price drop and uncertainty on interest rates. GSK's profit forecast improved, while Aston Martin faced widened losses.
GSK Says Pfizer Infringed Five Patents Relating to Comirnaty COVID VaccineGlaxoSmithKline (GSK) filed a complaint alleging Pfizer and BioNTech's COVID-19 vaccines used GSK's patented inventions, highlighting unacknowledged revolutionary platform application.